AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020
Aug 6, 2020
30583_dirs_2020-08-05_ba90d8dd-c166-4527-9dc9-3b2b733acd1a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-08-03
Reporting Person: GREY MICHAEL G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-03 | Common Stock | M | 2500 | $26.49 | Acquired | 45340 | Direct |
| 2020-08-03 | Common Stock | S | 2500 | $120.35 | Disposed | 42840 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-03 | Stock Option (Right to buy Common Stock) | $26.49 | M | 2500 | Disposed | 2021-05-11 | Common Stock (2500) | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on June 12, 2020.
F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19